# Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation

> **NCT01218737** · PHASE3 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 101 (actual)

## Conditions studied

- Ocular Infection and Inflammation

## Interventions

- **DRUG:** 0.3% gatifloxacin and 1.0% prednisolone acetate association
- **DRUG:** isolated 0.3% gatifloxacin and 1.0% prednisolone acetate

## Key facts

- **NCT ID:** NCT01218737
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2018-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218737, "Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01218737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*